References

10.3390/cancers15205096

10.3390/cancers15205096 · External reference

10.3390/cancers14071716

10.3390/cancers14071716 · External reference

Concentration of hypoxia-inducible factor-1, glucose transporter 1 and vascular endothelial growth factor in tissue samples and serum in patients with primary laryngeal carcinoma

10.1080/00016489.2022.2085885 · 2022 · External reference

10.3390/ph17020195

10.3390/ph17020195 · External reference

Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma

10.3892/ol.2012.941 · 2013 · External reference

Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma

2012 · External reference

Molecular-targeted therapy hypoxia in head and neck squamous cell carcinoma patients

10.3892/mco.2012.17 · 2013 · External reference

Hypoxia in head and neck squamous cell carcinoma

10.5402/2012/708974 · 2012 · External reference

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

1992 · External reference

Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia

10.1016/s0021-9258(20)80571-7 · 1993 · External reference

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

10.1073/pnas.92.12.5510 · 1995 · External reference

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

10.1073/pnas.95.14.7987 · 1998 · External reference

A conserved family of prolyl-4-hydroxylases that modify HIF

10.1126/science.1066373 · 2001 · External reference

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

10.1016/s0092-8674(01)00507-4 · 2001 · External reference

HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia

10.1093/emboj/cdg392 · 2003 · External reference

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

10.1038/20459 · 1999 · External reference

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing

10.1126/science.1059817 · 2001 · External reference

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

10.1126/science.1059796 · 2001 · External reference

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

10.1101/gad.991402 · 2002 · External reference

Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803

10.1042/bj20021162 · 2002 · External reference

Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: Evidence against a regulatory role for Src kinase

10.1182/blood.v89.2.503 · 1997 · External reference

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

10.1101/gad.12.2.149 · 1998 · External reference

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

10.1128/mcb.16.9.4604 · 1996 · External reference

Hypoxia-inducible factor-1 in tumour angiogenesis

10.3748/wjg.v10.i8.1082 · 2004 · External reference

Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1

10.1016/s0021-9258(17)31580-6 · 1994 · External reference

HIF-1: Upstream and downstream of cancer metabolism

10.1016/j.gde.2009.10.009 · 2010 · External reference

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

10.1016/j.cmet.2006.02.002 · 2006 · External reference

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations

10.1172/jci67230 · 2013 · External reference

HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors

2001 · External reference

Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains

10.1128/mcb.00166-09 · 2009 · External reference

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

10.1073/pnas.1113483108 · 2011 · External reference

Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma

2009 · External reference

Hypoxia and the extracellular matrix: Drivers of tumour metastasis

10.1038/nrc3726 · 2014 · External reference

Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies

10.1155/2015/549412 · 2015 · External reference

Hypoxia-induced angiogenesis: Good and evil

10.1177/1947601911423654 · 2011 · External reference

HIF-1α pathway: Role, regulation and intervention for cancer therapy

10.1016/j.apsb.2015.05.007 · 2015 · External reference

Regulation of metabolism by hypoxia-inducible factor 1

10.1101/sqb.2011.76.010678 · 2011 · External reference

Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia

10.1074/jbc.m010144200 · 2001 · External reference

Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells

10.1677/joe.1.05599 · 2004 · External reference

Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells

10.1165/ajrcmb.21.6.3751 · 1999 · External reference

The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis

10.1101/gad.1529107 · 2007 · External reference

10.3390/ijms20020238

10.3390/ijms20020238 · External reference

Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension

10.1074/jbc.272.31.19253 · 1997 · External reference

Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha

10.1073/pnas.082117899 · 2002 · External reference

HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation

10.1073/pnas.181341498 · 2001 · External reference

Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha

10.1128/mcb.25.15.6415-6426.2005 · 2005 · External reference

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth

10.1073/pnas.94.15.8104 · 1997 · External reference

Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1

10.1074/jbc.271.51.32529 · 1996 · External reference

Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells

10.3892/ol.2013.1321 · 2013 · External reference

Expression of glucose transporter-1, hypoxia inducible factor-1α and beclin-1 in head and neck cancer and their implication

2018 · External reference

Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer

10.1111/coa.13789 · 2021 · External reference

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

10.1126/science.6823562 · 1983 · External reference

Vascular endothelial growth factor is a secreted angiogenic mitogen

10.1126/science.2479986 · 1989 · External reference

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

10.1038/359843a0 · 1992 · External reference

VEGF signalling: Integration and multi-tasking in endothelial cell biology

10.1042/bst0311171 · 2003 · External reference

Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition

10.1016/j.cellsig.2007.05.013 · 2007 · External reference

Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

10.1200/jco.2002.10.088 · 2002 · External reference

Angiogenesis in cancer and other diseases

10.1038/35025220 · 2000 · External reference

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

10.1200/jco.2005.06.081 · 2005 · External reference

Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: An immunohistochemical study

10.1080/00016489950180711 · 1999 · External reference

Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma

10.1007/s004280050037 · 2000 · External reference

Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy

10.1002/cncr.22432 · 2007 · External reference

Serum levels of vascular endothelial growth factor in patients with head and neck cancer

10.1007/s004059900208 · 2000 · External reference

Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma

10.1002/hed.10163 · 2002 · External reference

Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy

10.1016/j.amjoto.2006.06.015 · 2007 · External reference

Facilitative glucose transporters

10.1111/j.1432-1033.1994.tb18550.x · 1994 · External reference

Structure, function, and regulation of the mammalian facilitative glucose transporter gene family

10.1146/annurev.nu.16.070196.001315 · 1996 · External reference

Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters

10.1007/s00109-015-1307-x · 2016 · External reference

Targeting Cancer Metabolism—Revisiting the Warburg Effects

10.5487/tr.2016.32.3.177 · 2016 · External reference

Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy

10.1177/10732748211041243 · 2021 · External reference

Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix

2001 · External reference

Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis

10.1007/s13277-014-2838-4 · 2015 · External reference

Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: A role for exosomes in metabolic switch of liver nonparenchymal cells

10.1096/fj.201802675r · 2019 · External reference

Hypoxia-inducible factor 1 (HIF-1) pathway

10.1126/stke.4072007cm8 · 2007 · External reference

VEGF in biological control

10.1002/jcb.21579 · 2007 · External reference

The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis

10.1016/s1044-579x(02)00103-7 · 2003 · External reference

The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism

10.1016/j.gendis.2016.11.003 · 2016 · External reference

Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1α under hypoxic conditions in Hep-2 human cells

10.3892/mmr.2012.1075 · 2012 · External reference

Expression of HIF-1alpha and VEGF in human laryngeal carcinoma and its relationship with angiogenes

2014 · External reference

Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia

10.1124/mol.107.038851 · 2008 · External reference

10.3390/biomedicines9020147

10.3390/biomedicines9020147 · External reference

Regulation of glycolysis in head and neck squamous cell carcinoma

10.14304/surya.jpr.v5n1.4 · 2017 · External reference

Effect of GLUT1 Inhibition and Autophagy Modulation on the Growth and Migration of Laryngeal Carcinoma Stem Cells Under Hypoxic and Low-Glucose Conditions

10.2147/ott.s300423 · 2021 · External reference

In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT

10.18632/oncotarget.16671 · 2017 · External reference

Effect of Glut-1 and HIF-1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway

10.1111/jcmm.17303 · 2022 · External reference

Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma

2007 · External reference

Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT

10.1007/s12032-015-0716-6 · 2016 · External reference

Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: An in vitro study

2014 · External reference

10.1371/journal.pone.0145375

10.1371/journal.pone.0145375 · External reference

Ensuring sample quality for blood biomarker studies in clinical trials: A multicenter international study for plasma and serum sample preparation

10.21037/tlcr.2017.09.13 · 2017 · External reference

The Expression of Hypoxia-Related Biomarkers: A Significance of HIF-1α C1772T Polymorphism as Predictor of Laryngeal Carcinoma Relapse

10.1177/10732748221144457 · 2022 · External reference

Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer

10.3858/emm.2009.41.1.007 · 2009 · External reference

Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma

10.1002/ijc.11068 · 2003 · External reference

Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer

10.1007/bf02893436 · 2007 · External reference

Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis

2007 · External reference

Significance of hypoxia in uterine cervical cancer. Multicentre study

2007 · External reference

Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival

10.3748/wjg.v11.i11.1705 · 2005 · External reference

GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis

10.2353/ajpath.2009.080596 · 2009 · External reference

Expressions and Significance of ALDH1, HIF-1α and VEGF in Laryngeal Squamous Cell Carcinoma

2017 · External reference

The expression and correlation of HMGB1 and VEGF protein in laryngeal squamous cell carcinoma

2011 · External reference

Angiogenic factors in laryngeal carcinomas: Do they have prognostic relevance?

10.1080/00016489950181846 · 1999 · External reference

10.1186/s12885-018-4180-5

10.1186/s12885-018-4180-5 · External reference

Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma

10.1002/lary.20483 · 2009 · External reference

10.3390/cancers12082059

10.3390/cancers12082059 · External reference

Macrophageal infiltration and microvessel density in laryngeal carcinoma: Study of 52 cases

10.14639/0392-100x-588 · 2015 · External reference

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

10.1152/ajpcell.1996.271.4.c1172 · 1996 · External reference

Influence of oxygen concentration and pH on expression of hypoxia induced genes

10.1016/j.radonc.2005.06.037 · 2005 · External reference

Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH

10.1016/j.radonc.2007.04.028 · 2007 · External reference

HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma

10.1002/hed.23620 · 2015 · External reference

Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review

10.1111/coa.13540 · 2020 · External reference

Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma

10.7150/ijms.6855 · 2013 · External reference

The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer: Relationship with radioresistance

10.1046/j.1365-2273.2001.00512.x · 2001 · External reference

Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro

10.2147/ott.s176818 · 2018 · External reference

Mitochondrial apoptosis induced by MNAT1 in laryngeal squamous cell carcinoma cells reverses drug resistance

10.1016/j.tranon.2025.102460 · 2025 · External reference

Wnt1-inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1/TEAD1/GLUT1 pathway

10.1002/jcp.28253 · 2019 · External reference

LARS promotes hepatocellular carcinoma progression via the PI3K/AKT/mTOR pathway and interaction with RPS5, and serves as a prognostic biomarker

10.1186/s10020-026-01490-9 · 2026 · External reference

Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: Which is the optimal specimen?

2000 · External reference

10.1371/journal.pone.0019873

10.1371/journal.pone.0019873 · External reference

Enzyme-Linked Immunosorbent Assay: Types and Applications

10.1007/978-1-0716-2903-1_1 · 2023 · External reference

Antibody validation of immunohistochemistry for biomarker discovery: Recommendations of a consortium of academic and pharmaceutical based histopathology researchers

10.1016/j.ymeth.2014.01.018 · 2014 · External reference

ELISA in the multiplex era: Potentials and pitfalls

10.1002/prca.201400130 · 2015 · External reference

10.1371/journal.pone.0270232

10.1371/journal.pone.0270232 · External reference

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology

10.1038/bjc.1998.158 · 1998 · External reference

Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation

10.1164/ajrccm.161.6.9905022 · 2000 · External reference

Clinical implications of intratumor heterogeneity: Challenges and opportunities

10.1007/s00109-020-01874-2 · 2020 · External reference

Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumour MARKer prognostic studies (REMARK)

10.1038/sj.bjc.6602678 · 2005 · External reference

Design of clinical trials for biomarker research in oncology

2011 · External reference

10.3390/cancers14122858

10.3390/cancers14122858 · External reference

10.3390/cancers15061826

10.3390/cancers15061826 · External reference

The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation

2022 · External reference

Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer

10.1007/s00259-016-3429-y · 2016 · External reference